SCHEMBL7894236

SCHEMBL7894236

CC(Nc1c(NCc2cccc(OC(F)(F)F)c2)c(=O)c1=O)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM2 Q14416 1/20 0.45
▸ PLK1 P53350 4/20 0.45
▸ KDM5A P29375 1/20 0.43
▸ KDM4C Q9H3R0 1/20 0.43
▸ KDM5B Q9UGL1 1/20 0.43
▸ MAPK14 Q16539 1/20 0.42
▸ KCNN3 Q9UGI6 1/20 0.41
▸ ROCK2 O75116 3/20 0.40
▸ ROCK1 Q13464 3/20 0.40
▸ CARM1 Q86X55 2/20 0.40
▸ PRMT6 Q96LA8 2/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ KCNB1 Q14721 1/20 0.39
▸ CHEK1 O14757 3/20 0.39
▸ DAPK3 O43293 2/20 0.39
▸ CHEK2 O96017 2/20 0.39
▸ GSK3A P49840 2/20 0.39
▸ GSK3B P49841 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8635955 1.00 GRM2 (0.45) GRM2PLK1KDM5AKDM4CKDM5B
SCHEMBL7895179 0.86 PLK1 (0.53) PLK1ROCK2ROCK1CHEK1DAPK3
SCHEMBL8634293 0.86 PLK1 (0.53) PLK1ROCK2ROCK1CHEK1DAPK3
SCHEMBL7898357 0.83 GRM2 (0.48) GRM2KDM5AKDM4CKDM5BMAPK14
SCHEMBL8633108 0.82 CHEK1 (0.58) PLK1ROCK2ROCK1CHEK1DAPK3
SCHEMBL7894058 0.82 CHEK1 (0.58) PLK1ROCK2ROCK1CHEK1DAPK3
SCHEMBL8639166 0.74 CHEK1 (0.47) PLK1ROCK2ROCK1CHEK1DAPK3
SCHEMBL7887005 0.74 CHEK1 (0.47) PLK1ROCK2ROCK1CHEK1DAPK3
SCHEMBL7894756 0.74 PLK1 (0.48) PLK1ROCK2ROCK1CHEK1DAPK3
SCHEMBL7894753 0.74 PLK1 (0.48) PLK1ROCK2ROCK1CHEK1DAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1151990-A1 Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones AMERICAN HOME PRODUCTS CORPORATION (US) 2001-11-07 — — EP claimed
EP-0934257-A1 SUBSTITUTED N-ARYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES AMERICAN HOME PRODUCTS CORPORATION (US) 1999-08-11 — — EP claimed
US-5750574-A ADMINISTERING TO REDUCE THE EFFECTS OF SMOOTH MUSCLE CONTRACTIONS AMERICAN HOME PRODUCTS CORPORATION (US) 1998-05-12 — — US claimed
WO-1998002413-A1 SUBSTITUTED N-ARYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES AMERICAN HOME PRODUCTS CORPORATION (US) 1998-01-22 — — WO claimed
EP-1151990-A1 Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones AMERICAN HOME PRODUCTS CORPORATION (US) 2001-11-07 — — EP disclosed
EP-0934257-A1 SUBSTITUTED N-ARYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES AMERICAN HOME PRODUCTS CORPORATION (US) 1999-08-11 — — EP disclosed
US-5750574-A ADMINISTERING TO REDUCE THE EFFECTS OF SMOOTH MUSCLE CONTRACTIONS AMERICAN HOME PRODUCTS CORPORATION (US) 1998-05-12 — — US disclosed
WO-1998002413-A1 SUBSTITUTED N-ARYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES AMERICAN HOME PRODUCTS CORPORATION (US) 1998-01-22 — — WO disclosed
Send feedback